Bronchial Thermoplasty Catheter Market By End-User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Executive Summary

According to the report titled, 'Bronchial Thermoplasty Catheter Market,' the bronchial thermoplasty catheter market was valued at $3.4 billion in 2021, and is estimated to reach $5.4 billion by 2031, growing at a CAGR of 5% from 2022 to 2031.

Bronchial thermoplasty is an approved technique for adults suffering from severe asthma. Asthma is a chronic respiratory disease characterized by recurrent attacks of wheezing and breathlessness. During an asthma attack, the lining of the bronchial tubes swells, causing the airways to narrow, turn more sensitive to irritants in the environment, thereby reducing the flow of air into and out of the lungs.

Both toddlers and adults can develop asthma over time. Inflammation and muscular contractions surrounding the tiny airways cause the airways in the lungs to become constricted. This results in asthma symptoms as coughing, wheezing, shortness of breath, and tightness in the chest. These intermittent symptoms are frequently worst at night or after activity. Other typical causes may exacerbate asthma symptoms. Depending on the individual, triggers may include viral illnesses (colds), dust, smoking, fumes, seasonal changes, grass and tree pollen, animal fur and feathers, potent soaps, and perfume.

When various therapies fail to control an asthmatic patient's symptoms, surgery is only considered. It is only used when other therapies fail to control an asthmatic patient's symptoms. Heat is applied during the treatment to weaken the muscles that restrict the airways. The airways are less sensitive and do not narrow as much during an asthma attack when there is less ASM. In patients 18 and older with severe chronic asthma who are being treated with long-acting beta agonists and inhaled corticosteroids, the Alair Bronchial Thermoplasty System is suggested.

Patients with asthma may benefit from bronchial thermoplasty, which helps to prevent long-lasting structural changes in the airway smooth muscle (ASM). Using a special catheter, bronchial thermoplasty permits the exact administration of radiofrequency radiation to the airway wall.

Some of these thicker muscle tissues are removed during bronchial thermoplasty, allowing the airways to open up. In addition, it lessens the possibility of future airways narrowing and constricting. Therefore, the patient is able to breathe more comfortably and experience fewer asthma attacks and reduced hospital visits. Patients treated with bronchial thermoplasty experience a decline in the number of severe asthma attacks, lesser visits to the hospital emergency room, as well as an improvement in quality of life. For those with severe asthma who are unable to manage their symptoms with ongoing medications, bronchial thermoplasty therapy is an option. All these factors are estimated to drive the market growth during the forecast years.

Government limitations on product approval are the primary factor impeding market expansion. Additionally limiting market expansion are the availability of complementary medicines and the issues with bronchial thermoplasty catheter. It calls for the application of iodinated subpar divergence. If there is severe present renal failure, this is nephrotoxic and should be avoided. Radiation exposure is also costly and challenging to afford.

Bronchial thermoplasty catheters are projected to be in higher demand as the number of minimally invasive procedures increases as a result of recent advances in technology. For instance, thermoplasty is becoming more popular than other surgeries due to its minimally invasive nature, which benefits the market's expansion. The expansion of the global bronchial thermoplasty catheters market is also anticipated to benefit from the rising number of product approvals, which will create lucrative bronchial thermoplasty catheter market opportunities. For instance, Cerus Endovascular's 027 micro-catheter, which contours the neurovascular system, was approved by the US Food and Drug Administration in March 2022.

The bronchial thermoplasty catheter market is segmented into end user and region. On the basis of end user, the market is classified into hospitals and ambulatory surgery centers. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, Italy, France, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA).

The key players profiled in the study include Boston Scientific and others. The players in the market have been actively engaged in the adoption of various Strategies such as acquisition, product launch, and expansion to remain competitive and gain an advantage over the competitors in the market. For instance, in September 2021 - Boston Scientific Corporation, signed a formal merger agreement with Asthmatx, Inc., a privately held business in Sunnyvale, California.

Key Market Insights

By end user, the hospitals segment was the highest revenue contributor to the market. The factors contributing to this segment's dominance are better healthcare infrastructure, the availability of skilled labor, and affordability. The increase in patient pool as a result of significant growth in the geriatric population suffering from lifestyle diseases such as atherosclerosis and heart failure is predicted to boost hospital income production.

Based on region, North America was the highest revenue contributor in the market, accounting for $3,409 million in 2021

Companies Mentioned

• Boston Scientific Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.